Viewing Study NCT04485156


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-23 @ 2:59 PM
Study NCT ID: NCT04485156
Status: NOT_YET_RECRUITING
Last Update Posted: 2020-07-24
First Post: 2020-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
Sponsor: Seoul National University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis, Pulmonary View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tuberculosis View
None Treatment View
None Shortening View
None Rifampicin View